UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 4, 2008
GENOMIC HEALTH, INC.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
(State or other jurisdiction
of incorporation)
|
|
000-51541
(Commission
File Number)
|
|
77-0552594
(IRS Employer
Identification No.) |
|
|
|
301 Penobscot Drive, Redwood City, California
(Address of principal executive offices)
|
|
94063
(Zip Code) |
Registrants telephone number, including area code: (650) 556-9300
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of
Certain Officers; Compensatory Arrangements of Certain Officers.
On December 4, 2008, the Board of Directors of Genomic Health, Inc. (the Company) elected
Ginger L. Graham a member of the Board of Directors of the Company. A copy of the Companys press
release announcing Ms. Grahams election to the Board of Directors as an independent director is
attached as Exhibit 99.1 to this report and is incorporated herein by reference.
Item 7.01 Regulation FD Disclosure.
As disclosed under Item 5.02, on December 4, 2008, the Companys Board of Directors elected
Ginger L. Graham a member of the Board of Directors. The Companys press release announcing Ms.
Grahams election is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
Item 9.01 Financial Statements and Exhibits.
(c) Exhibits
|
|
|
|
|
Exhibit No. |
|
Description |
|
99.1 |
|
|
Press release issued by Genomic Health, Inc. dated December 8, 2008 |